Literature DB >> 21246209

Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis.

Stamatios Peridis1, Gemma Pilgrim, Ioannis Athanasopoulos, Konstantinos Parpounas.   

Abstract

The purpose of the study was to compare CA-9 positivity versus CA-9 negativity in head and neck malignancies and to correlate levels of CA-9 with tumor grade, size, and nodal status. Overall and disease-free survival were also compared for CA-9 positive and negative tumors. A literature search was performed using Medline, Embase, Ovid and Cochrane databases for studies between 1990 and 2009. Carbonic anhydrase IX, CA IX, CA-9, head and neck, and survival were used as search terms. Random-effect meta-analytical techniques were conducted for outcome measures of overall survival and disease-free survival. Sixteen studies matched the selection criteria, reporting on 1,470 patients. Eight hundred and forty two specimens were reported as being CA-9 positive or negative: 512 (60.81%) were CA-9 positive and 330 (39.19%) were CA-9 negative. Nine hundred and eighty specimens had levels of CA-9 expression recorded: 547 (55.82%) had high levels of CA-9 and 433 (44.18%) had low CA-9 levels. Survival was significantly reduced if the tumor was positive for CA-9 (P < 0.0001). Disease-free survival is significantly reduced in patients with CA-9 positive (P = 0.0008) head and neck malignant tumors. The presence of CA-9 in head and neck malignant tumors is associated with reduced overall survival and disease-free survival. © Springer-Verlag 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21246209     DOI: 10.1007/s00405-011-1488-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  37 in total

1.  Bringing it all together: Lancet-Cochrane collaborate on systematic reviews.

Authors:  M Clarke; R Horton
Journal:  Lancet       Date:  2001-06-02       Impact factor: 79.321

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.

Authors:  Matthias Bache; Rolf Reddemann; Harun M Said; Hans-Jürgen Holzhausen; Helge Taubert; Axel Becker; Thomas Kuhnt; Gabriele Hänsgen; Jürgen Dunst; Dirk Vordermark
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-23       Impact factor: 7.038

4.  Galectin-1: a link between tumor hypoxia and tumor immune privilege.

Authors:  Quynh-Thu Le; Gongyi Shi; Hongbin Cao; Daniel W Nelson; Yingyun Wang; Eunice Y Chen; Shuchun Zhao; Christina Kong; Donna Richardson; Ken J O'Byrne; Amato J Giaccia; Albert C Koong
Journal:  J Clin Oncol       Date:  2005-10-11       Impact factor: 44.544

5.  Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; J Pastorek; C C Wykoff; K C Gatter; A L Harris
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

6.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.

Authors:  S K Chia; C C Wykoff; P H Watson; C Han; R D Leek; J Pastorek; K C Gatter; P Ratcliffe; A L Harris
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

7.  Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours.

Authors:  P Hynninen; L Vaskivuo; J Saarnio; H Haapasalo; J Kivelä; S Pastoreková; J Pastorek; A Waheed; W S Sly; U Puistola; S Parkkila
Journal:  Histopathology       Date:  2006-12       Impact factor: 5.087

8.  Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.

Authors:  Kårstein Måseide; Rita A Kandel; Robert S Bell; Charles N Catton; Brian O'Sullivan; Jay S Wunder; Melania Pintilie; David Hedley; Richard P Hill
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

9.  Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.

Authors:  David Hedley; Melania Pintilie; Jennifer Woo; Andrew Morrison; Diana Birle; Anthony Fyles; Michael Milosevic; Richard Hill
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

10.  Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.

Authors:  Marianne Nordsmark; Jesper Grau Eriksen; Val Gebski; Jan Alsner; Michael R Horsman; Jens Overgaard
Journal:  Radiother Oncol       Date:  2007-05-17       Impact factor: 6.280

View more
  13 in total

1.  Carbonic anhydrase IX overexpression regulates the migration and progression in oral squamous cell carcinoma.

Authors:  Jia-Sin Yang; Chiao-Wen Lin; Chun-Yi Chuang; Shih-Chi Su; Shu-Hui Lin; Shun-Fa Yang
Journal:  Tumour Biol       Date:  2015-07-01

2.  Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma.

Authors:  Fion L Sung; Yan Cui; Edwin P Hui; Lili Li; Thomas Ks Loh; Qian Tao; Anthony Tc Chan
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 3.  Molecular and cellular processes underlying the hallmarks of head and neck cancer.

Authors:  Jonathan M Bernstein; Clare R Bernstein; Catharine M L West; Jarrod J Homer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-23       Impact factor: 2.503

4.  Hypoxia in head and neck squamous cell carcinoma.

Authors:  John Zenghong Li; Wei Gao; Jimmy Yu-Wai Chan; Wai-Kuen Ho; Thian-Sze Wong
Journal:  ISRN Otolaryngol       Date:  2012-10-16

Review 5.  Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers.

Authors:  G Ilardi; N Zambrano; F Merolla; M Siano; S Varricchio; M Vecchione; G De Rosa; M Mascolo; S Staibano
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

6.  Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.

Authors:  Yuhan Chen; Xianming Li; Shihai Wu; Gang Xu; Yayan Zhou; Long Gong; Zihuang Li; Dong Yang
Journal:  Med Oncol       Date:  2014-11-07       Impact factor: 3.064

Review 7.  Current relevance of hypoxia in head and neck cancer.

Authors:  Marius G Bredell; Jutta Ernst; Ilhem El-Kochairi; Yuliya Dahlem; Kristian Ikenberg; Desiree M Schumann
Journal:  Oncotarget       Date:  2016-08-02

8.  Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis.

Authors:  Alejandro I Lorenzo-Pouso; Mercedes Gallas-Torreira; Mario Pérez-Sayáns; Cintia M Chamorro-Petronacci; Oscar Alvarez-Calderon; Bahi Takkouche; Claudiu T Supuran; Abel García-García
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

9.  Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.

Authors:  Shian-Shiang Wang; Yu-Fan Liu; Yen-Chuan Ou; Chuan-Shu Chen; Jian-Ri Li; Shun-Fa Yang
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 10.  Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.

Authors:  Simon J A van Kuijk; Ala Yaromina; Ruud Houben; Raymon Niemans; Philippe Lambin; Ludwig J Dubois
Journal:  Front Oncol       Date:  2016-03-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.